Matinas BioPharma (MTNB) Stock: Buy, Sell, or Hold?
MTNB - Matinas BioPharma Holdings, Inc.
$0.16
0.00 (-0.12%)
▼
5d:
-12.0%
30d:
-32.45%
90d:
-73.05%
WAIT
LOW Confidence
Analysis Updated: Sep 18, 2026 12:00 AM ET
Earnings: Nov 09, 2026
Get Alerted When MTNB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: MTNB is down 12.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: MTNB is down 12.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: MTNB is currently trading at $0.16, which is considered oversold relative to its 30-day fair value range of $0.17 to $0.23.
Technical Outlook: Technically, MTNB is in a strong downtrend. Immediate support is located at $0.15, while resistance sits at $0.20.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $30.00 (+18304.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MTNB is in a strong downtrend. Immediate support is located at $0.15, while resistance sits at $0.20.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $30.00 (+18304.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.17 -
$0.23
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (43/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 18304.9% below Wall St target ($30.00)
- WARNING: Composite score 47/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.17 -
$0.23
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.15
Resistance Level
$0.21
Current Trend
Strong Downtrend
Technical data as of
Sep 17, 2026
Fundamental Context
Wall Street Target
$30.00
(+18304.9%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: September 18, 2026 1:09 PM ET
Data refreshes hourly during market hours. Next update: 2:09 PM
Data refreshes hourly during market hours. Next update: 2:09 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MTNB showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 52 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 40 SELL |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$48 | 47 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$849 | 51 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$290 | 64 BUY |
